{"id":"https://openalex.org/W2951311906","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","title":"AB0744 EFFICACY OF IXEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AXIAL PAIN STARTING BEFORE AGE 45: A SUBGROUP ANALYSIS OF SPIRIT-P1 AND SPIRIT-P2 PHASE 3 CLINICAL TRIALS","display_name":"AB0744 EFFICACY OF IXEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS (PSA) PATIENTS WITH AXIAL PAIN STARTING BEFORE AGE 45: A SUBGROUP ANALYSIS OF SPIRIT-P1 AND SPIRIT-P2 PHASE 3 CLINICAL TRIALS","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2951311906","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","mag":"2951311906"},"language":"en","primary_location":{"id":"doi:10.1136/annrheumdis-2019-eular.1235","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","is_oa":false,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","pdf_url":null,"source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111888136","display_name":"Atul A. Deodhar","orcid":"https://orcid.org/0000-0002-2130-1246","observed_orcids":["https://orcid.org/0000-0002-2130-1246"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atul Deodhar","raw_affiliation_strings":["Oregon Health and Science University, Portland, United States of america"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, United States of america","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014427334","display_name":"Alexis Ogdie","orcid":"https://orcid.org/0000-0002-4639-0775","observed_orcids":["https://orcid.org/0000-0002-4639-0775"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis Ogdie","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, United States of america"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, United States of america","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008516154","display_name":"Talia M. Muram","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Talia Muram","raw_affiliation_strings":["Eli Lilly and Company, indianapolis, United States of america"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, indianapolis, United States of america","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055902325","display_name":"David M. Sandoval","orcid":"https://orcid.org/0000-0002-9118-4321","observed_orcids":["https://orcid.org/0000-0002-9118-4321"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Sandoval","raw_affiliation_strings":["Eli Lilly and Company, indianapolis, United States of america"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, indianapolis, United States of america","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017170671","display_name":"Vladimir Geneus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vladimir Geneus","raw_affiliation_strings":["Eli Lilly and Company, indianapolis, United States of america"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, indianapolis, United States of america","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011826741","display_name":"Peter T. Nash","orcid":"https://orcid.org/0000-0002-2571-788X","observed_orcids":["https://orcid.org/0000-0002-2571-788X"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter Nash","raw_affiliation_strings":["University of Queensland, Brisbane, australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Queensland, Brisbane, australia","institution_ids":["https://openalex.org/I165143802"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4870,"currency":"USD","value_usd":4870},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":null,"first_page":"1838","last_page":"1838"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.9729999899864197},{"id":"https://openalex.org/keywords/ixekizumab","display_name":"ixekizumab","score":1.0},{"id":"https://openalex.org/keywords/axial-pain","display_name":"axial pain","score":0.9779999852180481},{"id":"https://openalex.org/keywords/axial-stiffness","display_name":"axial stiffness","score":0.5529999732971191},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8989999890327454},{"id":"https://openalex.org/keywords/physical-functioning","display_name":"physical function","score":0.8040000200271606},{"id":"https://openalex.org/keywords/bath-ankylosing-spondylitis-disease-activity-index","display_name":"BASDAI","score":0.6119999885559082},{"id":"https://openalex.org/keywords/health-assessment-questionnaire-disability-index","display_name":"HAQ-DI","score":0.8510000109672546},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9425980448722839},{"id":"https://openalex.org/C2777453003","wikidata":"https://www.wikidata.org/wiki/Q4834648","display_name":"BASDAI","level":4,"score":0.9069601893424988},{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.8597038984298706},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.7628166675567627},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6049973368644714},{"id":"https://openalex.org/C2777402515","wikidata":"https://www.wikidata.org/wiki/Q52849","display_name":"Ankylosing spondylitis","level":2,"score":0.522949755191803},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5127919316291809},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.5083076357841492},{"id":"https://openalex.org/C2776213234","wikidata":"https://www.wikidata.org/wiki/Q28867094","display_name":"Axial spondyloarthritis","level":4,"score":0.49641066789627075},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.41330233216285706},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4112085700035095},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.35557669401168823},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.11815780401229858},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07150900363922119},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0639394223690033},{"id":"https://openalex.org/C2778579456","wikidata":"https://www.wikidata.org/wiki/Q2213687","display_name":"Sacroiliitis","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/annrheumdis-2019-eular.1235","doi":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","is_oa":false,"landing_page_url":"https://doi.org/10.1136/annrheumdis-2019-eular.1235","pdf_url":null,"source":{"id":"https://openalex.org/S25650217","display_name":"Annals of the Rheumatic Diseases","issn_l":"0003-4967","issn":["0003-4967","1468-2060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of the Rheumatic Diseases","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7048063761","https://openalex.org/W3165803692","https://openalex.org/W4386124137","https://openalex.org/W3095410646","https://openalex.org/W3037845778","https://openalex.org/W2550837574","https://openalex.org/W2755704235","https://openalex.org/W4399177370","https://openalex.org/W3097362839","https://openalex.org/W2938777142"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2019-06-27T00:00:00"}